Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows Revision: v3.3.2 and no longer displays Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding lapse notice was removed from the page, and core study details (design, eligibility criteria, contacts, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new screenshot shows updated record history with the last update posted on 2024-11-12 and the last verification date. This indicates recent maintenance of the study record.SummaryDifference0.5%

- Check62 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top link was removed; overall this is a minor update with no substantive changes to core content.SummaryDifference0.3%

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.